Photo by Wirestock
The New York State Cannabis Control Board (CCB) gathered on September 9, for a meeting that underscored both the rapid maturation of the state’s legal cannabis market and the challenges that come with scaling a tightly regulated industry. With billions in projected sales, the Board’s agenda focused on licensing, supply management, regulatory modernization, and equity commitments.
Expanding Access While Guarding Against Oversupply
A central theme was cautious licensing expansion.
The state is closely monitoring cultivation capacity. After a 2022 surplus that led to degraded product quality and diversion to unregulated markets, regulators remain wary of repeating past mistakes. Acting Executive Director Felicia Reid confirmed that cultivation license approvals remain suspended pending the results of the 2025 growing season (aka Croptober). This harvest is expected to test whether current canopy space—estimated at 6.5 million square feet statewide—is properly aligned with in-state demand.
The policy represents a deliberate slowdown. While applicants have pressed for more cultivation opportunities, the Office of Cannabis Management (OCM) insists that responsible pacing is essential to prevent oversupply. In the past, oversupply has destabilized prices and undermined legal operators.
The Regulatory Updates on Everyone’s Mind: Proximity Rules
Two public convenience and advantage (PCA) requests, which essentially request exceptions to the regulations governing dispensary operations, came up for vote. Chair Jessica Garcia underscored that the current PCA standard remains in force until new rules are published.
“I know at the last meeting I had made the statement that we would be evaluating these PCA requests with the new regulations… but they have not yet been published. And so, for the time being, all PCA requests… will [use] the old, the current standard.”
Public testimony was frank. Tony Kelly of consulting company Interstate 420 said, “The past six months have been devastating for our businesses and for our communities.” He cited “delays, inconsistent guidance, and lack of communication,” that leave operators “burning through savings” and sometimes closing.
Another speaker, seeking a PCA determination, said, “This is not the equity process the law promised.”
Several commenters asked the Board to resolve PCA requests and reconcile mapping or measurement discrepancies; others urged program tweaks like farmer’s markets access for microbusiness retailers. Many cannabis operators cannot yet partake in the $2 billion market; they’re just out here trying to survive.
Licensing and Renewals
The September agenda also included votes on licenses and renewals. At the beginning of the meeting, the CCB noted that, “There’s 46 applicants in this month’s board packet, eight cultivators, 12 adult-use retail dispensaries, four microbusinesses, four distributors, 14 processors, and four [Conditional Adult-Use Retail Dispensary (CAURD)] licenses… If approved, this will bring the total number of adult use applications… to 1,904.”
- CAURD Renewals: The Board approved another round of CAURD license renewals. These conditional licenses, which prioritize justice-involved individuals, continue to serve as a backbone of New York’s equity framework. Several New York City CAURD dispensaries that were among the first to open in late 2022 successfully transitioned into their renewal period.
- Testing Laboratories: 14 cannabis testing labs received renewals. OCM confirmed that this number remains sufficient to serve both medical and adult-use markets.
- Research Licenses: Two new research licenses were approved, expanding studies on cannabis genetics, agricultural techniques, and potency standardization.
- Registered Organizations (ROs): The Board approved new RO facilities in western New York, where patients had faced limited medical access due to prior closures.
Equity and Community Engagement
Equity remains a defining pillar of New York’s cannabis rollout. But the meeting revealed growing frustration among small operators. During the public comment period, several licensees and applicants expressed hardship:
- Delayed Reviews: Cultivation applicants from late 2023 noted that they are paying rent on facilities without clarity on approvals.
- Grant Eligibility: Microbusinesses urged the Board to expand grant programs beyond CAURD licensees. They argued that many equity-minded entrepreneurs remain excluded.
- Operational Flexibility: Calls were made for updated guidance on refrigeration, product testing, and allowances for multi-serving edibles.
Former Chair Tremaine Wright acknowledged these concerns in the meeting. “We hear you. Our goal is to ensure businesses are not just licensed but supported to succeed.”
Still, Wright emphasized that equity implementation is a long-term process. That process, she explained, requires careful balance between inclusivity, compliance, and market stability.
Cannabis Education Advisory Panel
The Board voted to create the Cannabis Education Advisory Panel (CEAP). When presenting this resolution, the OCM’s Deputy Director of Public Health and Education Lyla Hunt said: “The establishment of the CEAP builds on the ongoing Listen and Learn series… [Communities] need credible, accessible resources on cannabis… [This] will be the first statewide body that’s dedicated to youth and family-centered cannabis education.”
Applications are open and will close on October 9, with a goal to seat the panel this fall. The OCM hopes to enlist 15 leaders in its efforts to educate New York families about cannabis.
Enforcement and the Fight Against Illicit Operators
Perhaps the sharpest critiques came around enforcement. Despite stepped-up efforts by the state and city, unlicensed dispensaries remain widespread. Several commenters stressed that illicit operators continue to undercut licensed shops by selling at lower prices and bypassing tax obligations.
CCB and OCM representatives reaffirmed their commitment to enforcement. But empowering licensed operators through marketing flexibility and access expansion may be the more effective long-term deterrent, they explained.
Looking Ahead
The meeting closed with a forward-looking agenda:
- Public Comments on Regulatory Revisions: Stakeholders have until late October to submit feedback on marketing and packaging changes.
- Croptober Analysis: The results of the 2025 harvest will heavily influence cultivation policy heading into 2026.
- Enforcement Actions: Updates are expected at the next Board meeting in October on joint state–city efforts to shutter unlicensed storefronts.
- Grant Programs: OCM hinted that they could announce new funding opportunities before year’s end, possibly expanding eligibility beyond CAURD participants.
The September CCB meeting reinforced the central paradox of New York’s cannabis experiment: the market is growing at a record-setting pace. Yet regulators must constantly calibrate to avoid oversupply, inequity, and competition from unlicensed operators.
For operators, the path forward is one of cautious optimism. The Board’s willingness to relax marketing restrictions and clarify proximity rules offers meaningful relief. But ongoing pauses on cultivation licensing remind the industry of regulators’ cautious hand.
As public comments roll in and Croptober’s harvest is tallied, the balance New York strikes between growth, sustainability, and fairness will shape not just the state’s cannabis landscape, but potentially the model for emerging markets nationwide.
Leave a Reply